Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

897779.pdf (927.89 KB)

Document type

Article

Version

Accepted version

Publication date

2024-12-01

Publication license

cc-by-nc-nd (c) Elsevier B.V., 2024
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/222896

Pharmaceutical Innovation Collaboration, Evaluation, and Matching

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/https://doi.org/10.1016/j.jhealeco.2024.102922

Abstract

This paper theoretically studies pharmaceutical innovation collaborations, where heterogeneous firms compete for heterogeneous academics. At an interim stage, the firm evaluates the project, which allows it to monitor academics and decide whether to terminate the project to avoid the loss from a future failure. This paper explores the contract, project termination strategy, and collaboration matching. The firm’s innovation strategy (exploitations or explorations) determines the evaluation structure, which may affect the market equilibrium. (...)

Subject

Gestió de la innovació, Tecnologia farmacèutica, Avaluació de l'assistència mèdica

Subject (English)

Innovation management, Pharmaceutical technology, Medical care evaluation

Citation

Collections

Articles publicats en revistes (Economia)

Citation

LIU, Qianshuo. Pharmaceutical Innovation Collaboration, Evaluation, and Matching. Journal of Health Economics. 2024. Vol. 98, num. 1-21. ISSN 0167-6296. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/222896

Export metadata

JSON - METS

Share record